[Inclusion-body myositis].

Area of Science:

• Neurology
• Immunology
• Pathology

Context:

• Sporadic inclusion-body myositis (sIBM) is a disabling neuromuscular disorder typically affecting individuals in their sixth decade.
• The disease primarily impacts skeletal muscles, characterized by a unique pattern of axial and limb muscle involvement, including distal muscles.

Purpose:

• To describe the clinical and histological features of sporadic inclusion-body myositis.
• To discuss the current understanding of sIBM's pathogenesis and the ineffectiveness of conventional treatments.

Summary:

• sIBM presents with specific muscle weakness patterns, diagnosed via muscle biopsy showing inflammatory infiltrates and rimmed vacuoles with amyloid deposits.
• The disease's etiology is debated, potentially involving degenerative or autoimmune processes, but standard immunosuppressants and immunoglobulins are ineffective.

Impact:

• Current therapeutic approaches for sIBM are limited, with standard immunosuppressive drugs often proving ineffective or detrimental.
• Maintaining muscle function through physical therapy is the primary strategy to slow disease progression, pending upcoming clinical trials.